MIT Researchers Uncover Potential Mechanism for Difficulty Processing New Information in Schizophrenia Schizophrenia, a complex and often debilitating mental health condition, is characterized by a constellation of symptoms that can profoundly impact an individual’s perception of reality, thought processes, and social functioning. Among the most pervasive and challenging aspects of the disorder is a marked difficulty in integrating new information with existing beliefs and understanding the world. This cognitive impairment not only complicates decision-making but can, over time, contribute to a profound disconnect from reality, manifesting as hallucinations and delusions. In a significant breakthrough, researchers at the Massachusetts Institute of Technology (MIT) have identified a specific gene mutation that appears to disrupt a critical brain circuit responsible for updating beliefs in response to novel information, offering a potential molecular explanation for this core cognitive deficit in schizophrenia. The groundbreaking research, published in the prestigious journal Nature Neuroscience, pinpoints a mutation in the grin2a gene. This gene had previously been implicated in large-scale genetic studies of schizophrenia, but its precise role in the disorder’s pathology remained elusive until now. Through meticulously designed experiments using genetically modified mice, the MIT team has provided compelling evidence that a disrupted grin2a gene function can impair the brain’s ability to dynamically adjust its understanding of the world as new data emerges. This finding opens promising avenues for therapeutic interventions targeting this specific brain circuit to alleviate the cognitive symptoms that significantly contribute to the burden of schizophrenia. "If this circuit doesn’t work well, you cannot quickly integrate information," stated Guoping Feng, the James W. and Patricia T. Poitras Professor in Brain and Cognitive Sciences at MIT, a distinguished member of the Broad Institute of Harvard and MIT, and the associate director of the McGovern Institute for Brain Research. "We are quite confident this circuit is one of the mechanisms that contributes to the cognitive impairment that is a major part of the pathology of schizophrenia." Feng, alongside Michael Halassa, an associate professor of psychiatry and neuroscience at Tufts University, served as senior authors of the study. The lead authors, Tingting Zhou, a research scientist at the McGovern Institute, and Yi-Yun Ho, a former MIT postdoctoral fellow, spearheaded the experimental work that yielded these critical insights. The Genetic Landscape of Schizophrenia: A Complex Inheritance Schizophrenia is widely recognized as a disorder with a substantial genetic predisposition. While the exact causes are multifactorial, involving a complex interplay of genetic and environmental factors, genetic influences play a pivotal role. In the general population, approximately 1% of individuals develop schizophrenia. This risk escalates significantly for those with a family history of the condition, rising to 10% for individuals with an affected parent or sibling, and reaching a striking 50% for identical twins, highlighting the strong heritable component. For decades, researchers have strived to unravel the genetic underpinnings of schizophrenia. Genome-wide association studies (GWAS), powerful tools for identifying genetic variations associated with diseases, have been instrumental in this endeavor. Scientists at the Stanley Center for Psychiatric Research at the Broad Institute, for instance, have identified over 100 distinct gene variants that are statistically linked to an increased risk of developing schizophrenia. However, a significant challenge has arisen from the fact that many of these identified variants are located in non-coding regions of DNA – often referred to as "junk DNA" – making it difficult to definitively ascertain their functional impact on gene expression and protein function. To overcome this interpretive hurdle, the research team employed whole-exome sequencing. This advanced technique focuses specifically on the protein-coding regions of the genome, known as exons. By concentrating on these critical areas, researchers can more directly identify mutations within genes that are likely to alter the structure or function of the proteins they encode. In their comprehensive analysis, the team meticulously examined approximately 25,000 exomes from individuals diagnosed with schizophrenia and compared them with around 100,000 exomes from control subjects. This rigorous comparative approach enabled them to pinpoint 10 specific genes where mutations were found to significantly elevate the risk of developing schizophrenia. The grin2a gene emerged as a prime candidate for further investigation due to its prior association with the disorder and its crucial role in neuronal function. Dissecting the Molecular Mechanism: How a Gene Mutation Alters Brain Function The focus of the new study was to elucidate the functional consequences of mutations within the grin2a gene. Researchers engineered laboratory mice to carry a specific mutation in this gene. The grin2a gene is vital for the production of a subunit of the N-methyl-D-aspartate (NMDA) receptor. NMDA receptors are a type of ionotropic glutamate receptor, ubiquitous in the brain and playing a fundamental role in synaptic plasticity, learning, and memory. They are activated by the neurotransmitter glutamate, which is the primary excitatory neurotransmitter in the mammalian central nervous system. Tingting Zhou, the lead author, then embarked on a series of behavioral experiments designed to assess whether these genetically modified mice exhibited behaviors analogous to those observed in schizophrenia. While it is impossible to directly model complex psychotic symptoms like hallucinations and delusions in rodents, scientists can effectively study related cognitive deficits, such as the impaired ability to interpret and respond to new sensory information. A prevailing hypothesis in schizophrenia research posits that psychosis may stem from a diminished capacity to update one’s beliefs when presented with new evidence. As Zhou explained, "Our brain can form a prior belief of reality, and when sensory input comes into the brain, a neurotypical brain can use this new input to update the prior belief. This allows us to generate a new belief that’s close to what the reality is." In contrast, Zhou continued, "What happens in schizophrenia patients is that they weigh too heavily on the prior belief. They don’t use as much current input to update what they believed before, so the new belief is detached from reality." This conceptual framework, often referred to as "predictive coding" or "Bayesian inference" in computational neuroscience, suggests that schizophrenia may involve a failure in the brain’s ability to appropriately recalibrate its internal models of the world. Experimental Evidence: Delayed Adaptive Decision-Making in Mutant Mice To rigorously test this hypothesis, Zhou designed a sophisticated behavioral task that required mice to make adaptive decisions in a dynamic environment. The experiment involved presenting the mice with a choice between two levers, each associated with a different reward magnitude. One lever offered a low reward: six presses were required to obtain a single drop of milk. The other lever provided a higher reward: only three presses were needed to receive three drops of milk. Initially, as expected, all mice demonstrated a preference for the high-reward lever, recognizing its greater efficiency. However, the experimental paradigm was designed to gradually alter the conditions. Over time, the effort required to obtain the reward from the high-reward lever progressively increased, while the low-reward lever remained constant. This manipulation created a scenario where the initial advantage of the high-reward option diminished. In this evolving scenario, neurotypical mice, serving as controls, exhibited adaptive behavior. As the effort for the high-reward lever became comparable to or exceeded that of the low-reward lever, they demonstrated the ability to adjust their strategy. They would eventually switch their preference to the low-reward lever, which had become the more efficient choice. This ability to adapt behavior based on changing environmental contingencies is a hallmark of flexible cognitive function. The mice engineered with the grin2a mutation, however, displayed a markedly different behavioral pattern. They continued to engage with both levers for a significantly longer duration, exhibiting a delayed commitment to the more efficient choice. Their decision-making process was slower and less flexible. "We find that neurotypical animals make adaptive decisions in this changing environment," Zhou observed. "They can switch from the high-reward side to the low-reward side around the equal value point, while for the animals with the mutation, the switch happens much later. Their adaptive decision-making is much slower compared to the wild-type animals." This behavioral deficit directly supports the hypothesis that the grin2a mutation impairs the ability to update beliefs and adjust behavior in response to new, contradictory information. Identifying the Neural Correlates: The Mediodorsal Thalamus Circuit Having established the behavioral consequences of the grin2a mutation, the researchers then sought to identify the specific brain regions and circuits involved. Employing advanced neuroimaging techniques, including functional ultrasound imaging and electrophysiological recordings, the team pinpointed the mediodorsal thalamus as a key area significantly affected by the mutation. The mediodorsal thalamus is a critical hub within the brain’s complex circuitry, playing a vital role in executive functions, decision-making, and working memory. It forms a crucial connection with the prefrontal cortex, a region responsible for higher-level cognitive processes. Together, the mediodorsal thalamus and the prefrontal cortex constitute a thalamocortical circuit that is fundamental for cognitive control and adaptive behavior. Within the mediodorsal thalamus of the mutant mice, the researchers observed distinct patterns of neural activity. Specifically, neurons in this region appeared to have a reduced capacity to track changes in the perceived value of different choices. Furthermore, the researchers noted alterations in neural firing patterns depending on whether the mice were actively exploring different options or had committed to a particular decision. This suggests that the mutation not only affects the representation of reward value but also disrupts the neural mechanisms underlying decision commitment. Therapeutic Potential: Reversing Symptoms by Activating the Circuit Perhaps the most encouraging aspect of the study is the demonstration that the behavioral deficits associated with the grin2a mutation could be reversed. Using a sophisticated technique called optogenetics, the researchers were able to genetically engineer neurons in the mediodorsal thalamus of the mutant mice to respond to light stimulation. By precisely activating these engineered neurons with targeted light pulses, the mice began to exhibit behaviors that were indistinguishable from those of their neurotypical counterparts. This remarkable finding provides compelling proof-of-concept that interventions aimed at modulating the activity of this specific brain circuit could hold therapeutic promise for individuals with schizophrenia. While mutations in grin2a may be present in only a subset of schizophrenia patients, the researchers propose that the underlying dysfunction in this thalamocortical circuit might represent a shared pathological mechanism that contributes to cognitive impairments across a broader spectrum of individuals with the disorder. The team is now actively engaged in the next critical phase of their research: identifying specific molecular targets within this circuit that could be modulated by pharmacological agents. The goal is to develop drugs that can restore the normal functioning of this belief-updating circuit, thereby alleviating the cognitive deficits that are so central to the experience of schizophrenia. Broader Implications and Future Directions The implications of this research extend beyond schizophrenia. The ability to update beliefs based on new information is a fundamental cognitive process essential for learning, adaptation, and navigating a complex world. Deficits in this capacity are likely to contribute to cognitive impairments in a range of neurological and psychiatric disorders. Therefore, the insights gained from this study could have far-reaching applications in understanding and treating other conditions characterized by cognitive rigidity or a detachment from reality. The study was supported by substantial funding from several prestigious institutions, including the National Institute of Mental Health, the Poitras Center for Psychiatric Disorders Research at MIT, the Yang Tan Collective at MIT, the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics at MIT, the Stelling Family Research Fund at MIT, the Stanley Center for Psychiatric Research, and the Brain and Behavior Research Foundation. This collaborative and well-funded effort underscores the scientific community’s commitment to unraveling the complexities of severe mental illness and developing effective treatments. As the research progresses, the scientific community will be keenly observing the development of potential therapeutic strategies. The identification of a specific gene mutation and its functional consequences on a critical brain circuit provides a tangible and promising target for intervention. This work represents a significant step forward in demystifying the intricate relationship between genetics, brain function, and the profound cognitive challenges faced by individuals living with schizophrenia, offering a beacon of hope for improved treatments and enhanced quality of life. Post navigation Genes Shape Canine Personalities: Cambridge Study Uncovers Shared Behavioral Roots Between Dogs and Humans
